← Back to Search

Right ventricular End diastolic pressure for Anesthesia

N/A

Recruiting

Led By adam adker, MD

Research Sponsored by Baylor College of Medicine

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients having undergone orthotropic heart transplantation

Patients requiring routine heart catheterization for post-transplant surveillance

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 10 minutes

Awards & highlights

Study Summary

This trial aims to understand the impact of a condition called atelectasis, which occurs when the lung tissue collapses, on the pressure inside the heart in children who have undergone a heart transplant. These children

Who is the study for?

This trial is for children who have had an orthotropic heart transplant and need routine heart catheterization to check for signs of rejection. They must be under general anesthesia during the procedure.Check my eligibility

What is being tested?

The study is looking at how lung tissue collapse (atelectasis), which can happen under general anesthesia, affects the pressure inside the heart after a child has received a new heart.See study design

What are the potential side effects?

Since this study focuses on observations rather than treatments, it does not directly involve side effects from interventions. However, general anesthesia itself may cause typical side effects like nausea, sore throat, or drowsiness.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have had a heart transplant.

Select...

I need regular heart checks after my organ transplant.

Select...

I will be put to sleep for surgery.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 10 minutes

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~10 minutes

This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of participants with reduction of right ventricular end diastolic pressure of 3mmHg or greater

Trial Design

1Treatment groups

Experimental Treatment

Group I: Right ventricular End diastolic pressureExperimental Treatment1 Intervention

Measurement of pre and post recruitment right ventricular end diastolic pressure

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Baylor College of MedicineLead Sponsor

1,001 Previous Clinical Trials

6,002,197 Total Patients Enrolled

adam adker, MDPrincipal InvestigatorTexas Childrens Hospital

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies available for patients to participate in this trial?

"Indeed, as indicated on clinicaltrials.gov, this trial is currently actively seeking eligible candidates. The initial posting date was November 20th, 2023 and the most recent update occurred on December 20th, 2023."

Answered by AI

How many individuals are currently enrolled as participants in this clinical trial?

"Indeed, the information available on clinicaltrials.gov confirms that this ongoing clinical trial is actively seeking eligible participants. It was initially posted for recruitment on November 20th, 2023 and subsequently updated on December 20th, 2023. The study aims to enroll a total of 15 participants from one location."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Impact of Atelectasis on RVEDP Following Orthotropic Heart Transplantation

Adam Adler MD, MS, FAAP 2023. "Impact of Atelectasis on RVEDP Following Orthotropic Heart Transplantation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06140810.